The disease abetalipoproteinemia results in intriguing disturbances of lipid transport (2, 3) . Included among its manifestations are an inability to form chylomicrons (4) and the lowest concentrations of plasma lipids detected in any human disorder. In this familial syndrome it is possible that the elaboration of beta lipoprotein, or more strictly its beta or B apoprotein, is primarily affected by mutation. This is one of two proteins known to be constituents of human plasma lipoproteins. Abetalipoproteinemia offers unique opportunities for probing the functions of and specific requirements for the B apoprotein and for observing compensating mechanisms aroused by its deficiency.
Some explorations into these aspects of the disease have already been made (2) (3) (4) (5) (6) . This paper adds the following studies: 1) more intensive immunochemical analyses of the plasma lipoproteins than have heretofore been made to determine whether any detectable quantities of beta lipoprotein are present, 2) identification of the protein present in the "low density lipoproteins" frequently reported in this disease, 3) examination of the alpha lipoproteins and their A apoprotein in abetalipoproteinemia, and 4) experimental determination of the effect of B apoprotein deficiency on endogenous glyceride transport.
Methods
Six patients with abetalipoproteinemia from four different kindreds were sources of samples for analyses:
* Submitted for publication September 7, 1965; ac- cepted December 16, 1965 . Presented in part before the Metabolism Section of the Fifty-seventh Annual Meeting of the American Society for Clinical Investigation Atlantic City, N. J., May 2, 1965 , and published in abstract form (1 Is ., a 12i-year-old male,' M. Sm., a 7-year-old male; and S. Sm., his 9-year-old sister. 2 One or more of the first four of these patients have been the subject of six previous publications (3, (7) (8) (9) (10) (11) . R. Kl. and L. Za. are the two original cases reported by Bassen and Kornzweig in 1950 . Two normal volunteers, B. W., a 21-year-old white female, and G. L., a 19-year-old white male, served as controls. Unless otherwise indicated all blood samples were collected in EDTA, 1 mg per ml, after an overnight fast. Lipoprotein fractionation was usually begun immediately; occasionally plasma was stored at 40 C for periods up to 2 days before analysis.
Preparative ultracentrifugation. Lipoprotein fractions were isolated in the preparative ultracentrifuge by techniques identical to those previously described (12 hours to permit isolation of any very low density lipoprotein (VLDL) (13) . Isotonic NaCl solution was usually added to the top and bottom fractions to return them to plasma concentrations before they were further utilized. All preparations were dialyzed preceding immunochemical analysis and extracted and analyzed in the same manner (12) . Three-ml aliquots of the plasma samples that were centrifuged directly at D 1.063 were also precipitated with heparin and manganese in the cold as an alternative method for determination of alpha lipoprotein (14) .
Paper electrophoresis. Paper electrophoresis with buffer containing albumin was used to identify lipoprotein fractions or separate plasma into four bands identified as chylomicrons, beta, pre-beta, and alpha lipoprotein (15) . Barbital buffer without albumin was also used for electrophoresis of some of the isolated lipoproteins. The paper strips were dried in an oven at 1000 C for 30 min-1 Sample kindly provided by Dr Immunochemistry. The techniques employed for immunoelectrophoresis and double diffusion on plates or in microtubes with either agar or agarose were previously described (12, 13) . The preparation and characteristics of the specific antisera to alpha or beta lipoproteins and the antiwhole human sera that were used were described earlier (12) . Plasma or lipoprotein solutions were concentrated at 40 C by extraction of water through a dialysis membrane into Sephadex G 50. Eight-to tenfold concentration of normal beta lipoprotein by this technique produced no evidence of denaturation or altered electrophoretic behavior. When solutions initially containing beta lipoprotein in amounts less than 1 of that in normal plasma (0.1 mg per 100 ml) were so concentrated, beta lipoprotein could still be identified by immunoelectrophoresis.
Antisera to lipoproteins in abetalipoproteinemia. Lipoproteins from the plasma of patients A. Co. and L. Za. were used intact as antigens, together with complete Freund's adjuvant (12) . The ultracentrifugal isolates of D < 1.21 (representing the high density and low density lipoproteins in the normal subject) and of D < 1.063 (normally containing all the low density lipoproteins) were used separately to challenge white New Zealand rabbits. D < 1.063 lipoproteins (representing 8 mg of protein) prepared from the top 2 ml of the supernate from 100 ml of plasma separated at D 1.063 from L. Za. were administered subcutaneously in three divided doses at 3-week intervals to one rabbit. The serum collected at the twelfth week was designated antiserum Rn. D < 1.21 lipoproteins, representing 30 mg of protein per rabbit and prepared from A. Co. and L. Za., were similarly used in two rabbits to prepare antisera Ru and Rn.
The precipitating antibodies in each antiserum were shown by immunoelectrophoresis to be yG-immunoglobulins (7 S y-globulins) (12 (17) , triglycerides (18) , and free fatty acids (FFA) (19) were measured in appropriate samples. Estimates of lipoprotein protein were made directly on nondelipidated lipoproteins by the method of Lowry, Rosebrough, Farr, and Randall (20) .
Protein analysis. The lipoproteins of D < 1.063 and of D < 1.21 in the plasmas of both patients were isolated with the ultracentrifuge, washed twice with recentrifugation at the same density, and dialyzed. Upon immunophoresis with three antiwhole human sera [H1, H2, and H3 as previously described (12)], only alpha lipoprotein was detectable. Samples of the lipoprotein fractions were extracted with 3: 2 ethanol ether (12) . The protein residues were hydrolyzed with 6 N HCl, and the amino acid compositions of hydrolysates representing 0.5 to 2 mg of protein were determined (12, 21) . Some of the extracted protein from the D < 1.21 lipoproteins was also dissolved in 1% performic acid for 1 hour and lyophilized before acid hydrolysis in order to oxidize sulfhydryl groups (12, 22 of that in the plasma of the control subjects, twothirds of whose plasma cholesterol floated at D 1.063 (Table I) .
Subfractionation of HDL was carried out on samples from three patients ( Table I) . As has been previously described by Farquhar and Ways (2) (Table I) (24) . Data from three patients with alpha lipoprotein deficiency (Tangier disease) (25) are shown in Table I for comparison.
Precipitation. When heparin and manganese were added to the plasma of the control subjects, the usual (14) large white flocculant precipitate appeared. Sufficient plasma was available from three patients with abetalipoproteinemia for similar treatment; it yielded only very small amounts of a gray precipitate that contained no material that could be identified as beta lipoproteins by immunoelectrophoresis. It did contain fibrinogen, albumin, y-globulin, and alpha lipoprotein as well as trace amounts of other plasma proteins. This precipitate was dissolved in concentrated salt solutions (5 N NaCl) and the excess salt removed by dialysis. Some lipid was detected in this material by staining after electrophoresis and immunoprecipitation, but it was all bound to alpha lipoprotein. The cholesterol concentrations in the supernatant solutions after precipitation with heparin and manganese differed from the concentrations of cholesterol in the HDL obtained by ultracentrifugation of the same plasma sample (Table I) . This difference in the apparent concentration of HDL as determined by the two methods in abetalipoproteinemia was in contrast to the excellent agreement of these methods with plasma samples from other subjects (0.2 + 1.8 mg per 100 ml, mean and SD of 46 samples) (13).
Electrophoresis. At least one plasma sample from all six patients with abetalipoproteinemia was subjected to paper electrophoresis. Numerous samples were run from patients L. Za. and A. Co. and the controls over a 2-year period, these PL = phospholipid, trig. = triglyceride, HDL2 = D 1.063 having been obtained at varying intervals after the subjects had eaten and while they were on various diets.
In abetalipoproteinemia only one lipoprotein band, and that having al mobility, was detected by paper electrophoresis even when the strips were overloaded (see Figure 4) (12) . Consistent with these earlier findings, the D 1.063 to 1.1 lipoproteins (HDL2) prepared from plasma of the two control subjects contained only the form of alpha lipoprotein called alpha LPA (12) . Their D 1.1 to 1.21 lipoproteins (HDL3) also contained alpha LPB. Alpha LPB has slower mobility on agar and agarose than alpha LPA and contains a lower ratio of lipid to protein (12) .
The immunochemical pattern of the alpha lipoproteins in each of the six patients with abetalipoproteinemia was qualitatively similar to that seen in normal subjects. Only alpha LPA was definitely detectable in fresh whole plasma or HDL2 lipoproteins prepared in the ultracentrifuge. Both alpha LPA and alpha LPB were present in HDL3 ( Figure 3 ). As in normal subjects, very small amounts of alpha LPB were present in the infranate after ultracentrifugation at D 1.21 although ultracentrifugation or storage seemed to result in less alpha LPB than is usually produced by these processes in normal subjects. Those alpha lipoproteins that floated at D 1.063 in abetalipoproteinemia plasma were of the alpha LPA form (Figure 2) . Abetalipoproteinemia plasma as an antigen. The antisera produced in rabbits by injection of lipoproteins from two of the patients are characterized in Table II . All three contained antibodies in relatively high titers to both forms of alpha lipoprotein (alpha LPA and alpha LPB). The lipoproteins used as antigens were not washed by repeated centrifugation as were the preparations of protein for amino acid analysis or those used previously (12) produce any changes in plasma triglyceride concentrations. These remained less than 20 mg per 100 ml throughout ( Figure 5 ). The plasma cholesterol and phospholipid concentrations also remained unchanged. Only alpha lipoproteins could be demonstrated immunochemically, and neither a chylomicron band nor a pre-beta lipoprotein band appeared ( Figure 4 ). There was no change in alpha lipoprotein titer on the different diets.
As demonstrated in at least ten other subjects (1, 13), alpha lipoprotein concentrations in the two control subjects on similar diets varied inversely with those of plasma triglycerides and pre-beta lipoproteins.
Discussion Both absence and deficiency of beta lipoproteins have been described in patients with abetalipoproteinemia (2-5, 9, 11, 30, 31 (13, 32) , but more complete delipidation usually denatures the protein residue (13, 32, 33) , making immunochemical analyses quite difficult. Proof is therefore lacking that apoprotein B would always be recognized by antisera that react with its lipid-laden form. The likelihood is great, however, that no B apoprotein is released into plasma in abetalipoproteinemia; it may never be synthesized at all.
These inferences and the experimental evidence from which they are derived form an interesting contrast to the analogous lipoprotein deficiency state, Tangier disease. Plasma from patients with this disease usually contains no detectable alpha lipoprotein line after immunophoresis with appropriate antisera. In concentrated plasma, however, especially when the semimicro Preer technique is utilized, some alpha lipoprotein can be demonstrated (34 nomena is an increase in the lipid carried by some of the available A apoprotein in abetalipoproteinemia. This could account for a reduction in the average density of the alpha lipoproteins and hence their unusual flotation pattern.
The available data do not prove "over-lipidation" of the apoprotein A, but indirect support was obtained in examination of the patients' lipoproteins after centrifugation. Less alpha LPB was produced by this procedure than is observed with normal plasma (12) . The transformation of the native alpha LPA to the immunochemically different alpha LPB form has previously been shown to be accompanied by loss of lipid (12) . When alpha LPA from plasma of patients with abetalipoproteinemia was delipidated by the more drastic treatment with organic solvents, it was all converted to alpha LPB.
When plasma concentrations of endogenous glyceride are increased by feeding high-carbohydrate diets ("carbohydrate induction"), the plasma concentration of "free" alpha lipoproteins decreases as that of pre-beta lipoproteins rises (13) . Under these conditions, patients with Tangier disease, who have only a tiny complement of alpha lipoproteins, cannot form pre-beta lipoproteins, but their plasma glyceride concentrations increase (13) .
Two of the patients with abetalipoproteinemia
were fed a diet that contained three times the amount of carbohydrate causing glycerides to rise within 3 days in normal subjects (36 Finally, it should be noted that another apoprotein, a "C peptide," has been described in glyceriderich plasma lipoproteins by Gustafson, Alaupovic, and Furman (38) . In our studies none of the 30 different antisera, which were prepared to antigens consisting of many different human lipoprotein fractions, detected such a third protein in normal VLDL (13) . The only lipid-staining precipitin lines produced by them with abetalipoproteinemia sera were clearly attributable to alpha lipoprotein. All of the plasma lipid having D < 1.063 was also precipitated with anti-alpha lipoprotein sera and the amino acid composition of all the lipoprotein protein that could be isolated was not detectably different from that of the normal A apoprotein. This failure to find evidence of a C peptide in abetalipoproteinemia will be of further interest and easier to interpret when more is learned about this possible new addition to the fat-transporting proteins. 
